RLG Acquires Litho and Label Company
Purchase helps expands business’ label and packing services.
Resource Label Group (RLG), a provider of label and packaging solutions, has acquired Pharmaceutic Litho and Label Company (PLLC), a manufacturer of printed inserts, labels, and packaging components for pharmaceutical, biotech, and medical device manufacturers.
PLLC will combine efforts with the recently acquired MedLit Solutions to expand and strengthen RLG’s national capabilities for the pharma and healthcare industries. Kevin Grogan, CEO of MedLit Solutions will lead the combined teams.
“We are delighted to welcome PLLC to the Resource Label Group family,” comments Mike Apperson, president and CEO of Resource Label Group. “The pharmaceutical and healthcare segments require a deep expertise and constant innovation to ensure the safety of their products. The combination of MedLit Solutions and PLLC further strengthens RLG’s pharmaceutical business and commitment to providing customers an exceptional full-service, national solution to support their increased needs and requirements.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
